Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock

被引:13
|
作者
Maybauer, Marc O. [1 ,2 ,3 ,4 ,5 ]
Maybauer, Dirk M. [1 ,2 ,3 ]
Fraser, John F. [4 ,5 ]
Szabo, Csaba [1 ,2 ]
Westphal, Martin [1 ,2 ]
Kiss, Levente [6 ]
Horvath, Eszter M. [6 ]
Nakano, Yoshimitsu [1 ,2 ]
Herndon, David N. [7 ,8 ]
Traber, Lillian D. [1 ,2 ]
Traber, Daniel L. [1 ,2 ]
机构
[1] Univ Texas Med Branch, Dept Anesthesiol, Invest Intens Care Unit, Galveston, TX 77555 USA
[2] Shriners Burns Hosp Children, Galveston, TX 77555 USA
[3] Univ Marburg, Dept Anaesthesiol & Intens Care, D-35033 Marburg, Germany
[4] Prince Charles Hosp Brisbane, Chermside, Qld 4032, Australia
[5] Univ Queensland, Crit Care Res Grp, Chermside, Qld 4032, Australia
[6] Semmelweis Univ, Inst Human Physiol & Clin Expt, H-1094 Budapest, Hungary
[7] Univ Texas Med Branch, Dept Surg, Galveston, TX 77550 USA
[8] Shriners Burns Hosp Children, Galveston, TX 77550 USA
基金
美国国家卫生研究院;
关键词
SMOKE-INHALATION INJURY; MICROVASCULAR BLOOD-FLOW; SEVERE SEPSIS; PEROXYNITRITE; HYPOTENSION; IMPROVES; MODEL; HEMODYNAMICS; VENTILATION; INHIBITION;
D O I
10.1186/cc9342
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: This prospective, randomized, controlled, experimental animal study looks at the effects of recombinant human activated protein C (rhAPC) on global hemodynamics and microcirculation in ovine acute lung injury (ALI) and septic shock, resulting from smoke inhalation injury. Methods: Twenty-one sheep (37 +/- 2 kg) were operatively prepared for chronic study and randomly allocated to either the sham, control, or rhAPC group (n = 7 each). The control and rhAPC groups were subjected to insufflation of four sets of 12 breaths of cotton smoke followed by instillation of live Pseudomonas aeruginosa into both lung lobes, according to an established protocol. Healthy sham animals were not subjected to the injury and received only four sets of 12 breaths of room air and instillation of the vehicle (normal saline). rhAPC (24 mu g/kg/hour) was intravenously administered from 1 hour post injury until the end of the 24-hour experiment. Regional microvascular blood flow was analyzed using colored microspheres. All sheep were mechanically ventilated with 100% oxygen, and fluid resuscitated with lactated Ringer's solution to maintain hematocrit at baseline levels. Results: The rhAPC-associated reduction in heart malondialdehyde (MDA) and heart 3-nitrotyrosine (a reliable indicator of tissue injury) levels occurred parallel to a significant increase in mean arterial pressure and to a significant reduction in heart rate and cardiac output compared with untreated controls that showed a typical hypotensive, hyperdynamic response to the injury (P < 0.05). In addition, rhAPC significantly attenuated the changes in microvascular blood flow to the trachea, kidney, and spleen compared with untreated controls (P < 0.05 each). Blood flow to the ileum and pancreas, however, remained similar between groups. The cerebral blood flow as measured in cerebral cortex, cerebellum, thalamus, pons, and hypothalamus, was significantly increased in untreated controls, due to a loss of cerebral autoregulation in septic shock. rhAPC stabilized cerebral blood flow at baseline levels, as in the sham group. Conclusions: We conclude that rhAPC stabilized cardiovascular functions and attenuated the changes in visceral and cerebral microcirculation in sheep suffering from ALI and septic shock by reduction of cardiac MDA and 3-nitrotyrosine.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] IMPACT OF RECOMBINANT HUMAN ACTIVATED PROTEIN C IN TREATMENT OF SEPTIC SHOCK IN A COMMUNITY HOSPITAL: IMPACT STUDY
    Hamidjaja, L.
    Gill, N.
    Shen, B.
    Balasubramanian, V.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (02) : 421 - 421
  • [22] Hemodynamic effects of recombinant human protein C in patients with septic shock
    Sanchez, Baltasar
    Piacentini, Enrique
    Pradella, Vittorio
    Mignini, Mariano
    Nava, Juan
    JOURNAL OF CRITICAL CARE, 2010, 25 (02) : 343 - 347
  • [23] Budesonide/Formoterol Attenuates Cardiovascular Dysfunction Related To Acute Lung Injury In Mice
    Suda, K.
    Eom, I.
    Or, C.
    Mui, T.
    Jaw, D.
    Li, Y.
    Bai, N.
    Ngan, D.
    Lee, J.
    Kim, J.
    Man, J.
    Kitagawa, Y.
    Man, S. P.
    Van Eeden, S.
    Sin, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [24] Recombinant human activated protein C reduces 3-nitrotyrosine levels in ovine acute lung injury and sepsis
    Maybauer, MO
    Maybauer, DM
    Fraser, JF
    Traber, LD
    Pertuis, KR
    Huda, R
    Parish, LP
    Enkhbaatar, P
    Murakami, K
    Nakano, Y
    Traber, DL
    FREE RADICAL BIOLOGY AND MEDICINE, 2005, 39 : S51 - S51
  • [25] DEXAMETHASONE AND RECOMBINANT HUMAN ACTIVATED PROTEIN C IMPROVE MYOCARDIAL FUNCTION AND EFFICIENCY DURING EXPERIMENTAL SEPTIC SHOCK
    Lemarie, Jeremie
    Blet, Alice
    Bouazza, Youcef
    Boisrame-Helms, Julie
    Meziani, Ferhat
    Levy, Bruno
    SHOCK, 2014, 41 (06): : 522 - 527
  • [26] EVALUATION OF THE CARDIAC EFFECTS OF RECOMBINANT HUMAN ACTIVATED PROTEIN C ADMINISTERED AT DIFFERENT MOMENTS IN EXPERIMENTAL SEPTIC SHOCK
    Otsuki, D. A.
    Fantoni, D. T.
    Pasqualucci, C. A.
    Auler, J. O.
    SHOCK, 2013, 39 : 106 - 106
  • [27] Efficacy of Therapy with Recombinant Human Activated Protein C of Critically Ill Surgical Patients with Infection Complicated by Septic Shock and Multiple Organ Dysfunction Syndrome
    Barie, Philip S.
    Hydo, Lynn J.
    Shou, Jian
    Eachempati, Soumitra R.
    SURGICAL INFECTIONS, 2011, 12 (06) : 443 - 449
  • [28] Human Recombinant Activated Protein C (XIGRIS) Attenuates Cerulein-Induced Experimental Acute Pancreatitis
    Babu, B. I.
    Genovese, T.
    Mazzon, E.
    Crissafuli, C.
    Siriwardena, A. K.
    Cuzzocrea, S.
    PANCREAS, 2009, 38 (08) : 982 - 982
  • [29] Recombinant human activated protein C reduces cardiac 3-nitrotyrosine and malondialdehyde levels in ovine acute respiratory distress syndrome and septic shock
    MO Maybauer
    DM Maybauer
    JF Fraser
    L Kiss
    C Szabo
    LD Traber
    M Westphal
    S Rehberg
    P Enkhbaatar
    DS Prough
    DN Herndon
    DL Traber
    Critical Care, 13 (Suppl 1):
  • [30] On the Randomized Trial of Activated Protein C in Acute Lung Injury
    Guerin, Claude
    Richard, Jean-Christophe
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179 (02) : 172 - 173